Carolyn M Millar, MD, PhD1,2*, Priyanka Raheja, MBBS, MD3*, Allison P Wheeler, MD/MSCI4, Shrinath Kshirsagar, MD, MBBS5*, Christian Schoergenhofer, MD, PhD6*, Nicoletta C Machin, DO7,8, Cihan Ay9*, Almudena Tercero, PharmD10*, Hayley Lane10*, Christopher J Horvath, DVM, MS10*, Sandip Panicker, PhD10, Gary Patou, MD10*, Benjamin Kim, MD, MPhil10 and Savita Rangarajan, MD11,12
1Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
2Imperial College Healthcare NHS Trust, London, United Kingdom
3The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, United Kingdom
4Washington Center for Bleeding Disorders, Division of Pediatric Hematology/Oncology & Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA
5Advanced Center for Research in Oncology, Hematology and Rare Disorders (ACOHRD), K J Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India
6Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
7Hemophilia Center of Western Pennsylvania, Pittsburgh, PA
8Division of Classical Hematology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
9Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
10Star Therapeutics, Inc., South San Francisco, CA
11University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
12Hematology Laboratory, K J Somaiya Hospital and Research Centre, Mumbai, India